Clinical study of plasma adsorption integrated pulse high volume hemofiltration on hemodynamics and immune response in patients with septic shock

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044192

Enrollment

Unknown

Registered

2021-03-12

Start date

2021-03-10

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock

Interventions

B group:Plasma adsorption integrated pulse high volume hemofiltration therapy

A group:CRRT

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Two ICU doctors in the intensive care unit of Linyi Central Hospital screened the patients to meet the sepsis 3.0 diagnostic criteria for septic shock, that is, sepsis 3.0 = infection + SOFA score >= 2, and vasoactive drugs are still needed to maintain blood pressure after sufficient fluid resuscitation.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years old, active bleeding, advanced tumor, refused blood purification treatment.

Design outcomes

Primary

Measure	Time frame
Immunization index Province;	—

Secondary

Measure	Time frame
Hemodynamic parameters;	—

Countries

China

Contacts

Public ContactKong Lingchen

Linyi Central Hospital

klch0313@163.com+86 15106691551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026